Point72 Asset Management’s Loxo Oncology, Inc LOXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-990,719
Closed -$139M 1343
2018
Q4
$139M Buy
990,719
+476,119
+93% +$72.3M 0.68% 25
2018
Q3
$87.9M Buy
514,600
+196,900
+62% +$33.1M 0.36% 67
2018
Q2
$55.1M Buy
+317,700
New +$47.7M 0.22% 128

Other funds holding LOXO

Point72 Asset Management's LOXO Position: Q1 2019 in Review

Point72 Asset Management sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 990,719 shares — an estimated $139M sold.

Point72 Asset Management first reported a position in LOXO in Q2 2018 and held it in 3 quarters. The position peaked at $139M in Q4 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

  • Point72 Asset Management reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
  • Point72 Asset Management sold 990,719 Loxo Oncology, Inc shares in Q1 2019, an estimated $139M.
  • Point72 Asset Management first reported a position in Loxo Oncology, Inc in Q2 2018 and held it in 3 quarters.
  • Point72 Asset Management's Loxo Oncology, Inc position peaked at $139M in Q4 2018.
  • 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Point72 Asset Management's 13F filing for Q1 2019, filed 15 May 2019.